Vaughan Roxanne A
Department of Biochemistry and Molecular Biology, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58201-9037, USA.
J Pharmacol Exp Ther. 2004 Jul;310(1):1-7. doi: 10.1124/jpet.103.052423. Epub 2004 Apr 2.
The neuronal transporters for the monoamines dopamine, serotonin, and norepinephrine are plasma membrane proteins that serve vital functions in the reuptake and control of synaptic neurotransmitter levels. They are also targets for abused and therapeutic drugs and play pivotal roles in neurological disorders such as depression, schizophrenia, and Parkinson's disease. There is increasing evidence that some activities of these carriers are subject to acute control by treatments that affect phosphorylation pathways, but the molecular basis for this is not understood. Recent work suggests that these regulatory processes may involve phosphorylation of the transporters by protein kinase C and other kinases, and may occur by affecting intrinsic transport activity or by controlling transporter cell surface expression. Phosphorylation-mediated regulation of monoamine transporters provides the potential for acute presynaptic control of neurotransmitter levels during normal neurophysiologic events, and dysregulation of these processes may lead to inappropriate transmitter clearance that contributes to the etiology of neurological disorders.
单胺类神经递质多巴胺、5-羟色胺和去甲肾上腺素的神经元转运体是质膜蛋白,在突触神经递质水平的再摄取和控制中发挥着重要作用。它们也是滥用药物和治疗药物的作用靶点,在诸如抑郁症、精神分裂症和帕金森病等神经疾病中起关键作用。越来越多的证据表明,这些载体的某些活性受到影响磷酸化途径的处理的急性调控,但其分子基础尚不清楚。最近的研究表明,这些调节过程可能涉及蛋白激酶C和其他激酶对转运体的磷酸化,可能通过影响内在转运活性或通过控制转运体细胞表面表达而发生。磷酸化介导的单胺转运体调节为正常神经生理事件中神经递质水平的急性突触前控制提供了可能,而这些过程的失调可能导致递质清除不当,进而促成神经疾病的病因。